ConductScience.org, home

Paper25907296

S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.

Wu R and 6 others. Exp Cell Res, 2015. Cited by 74 papers, by iCite.

Cite this record

ConductScience Library. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways. Papers, record 25907296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25907296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
PubMed
Journal
Exp Cell Res
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
74
iCite
Relative citation ratio, by iCite
2.44
iCite
Revised in PubMed
2017-11-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu RRui
2Duan LLiang
3Cui FFang
4Cao JJu
5Xiang YYu
6Tang YYishu
7Zhou LLan

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calgranulin BMajor topic
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
MAP Kinase Signaling SystemMajor topic
Neoplasm InvasivenessMajor topic
Receptors, ImmunologicMajor topic
p38 Mitogen-Activated Protein KinasesMajor topic
Animals
Cell Proliferation
Cells, Cultured
Disease Models, Animal
Female
Hep G2 Cells
Humans
Liver Neoplasms, Experimental
Mice
Mice, Nude
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Receptor for Advanced Glycation End Products

Source PubMed

Download CSV of topics

Cited by56

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.

PMIDTitleJournalYearIn PapersSource
42675222Neuromedin U 'innervation' reprograms myeloid immunosuppression in neuroendocrine prostate cancer.Oncogene2026https://conductscience.org/library/papers/42675222PubMed
41513624Site-specific HPV18 integration facilitates cervical carcinogenesis through metabolic reprogramming-induced dysfunction of the SpHK1/S1P/S1PR1 pathway.Cell Death Dis2026https://conductscience.org/library/papers/41513624PubMed
41272764S100A9 regulates eosinophil extracellular trap and activates NF-κB signaling in endometrial cancer: a machine learning-based biomarker discovery.Cancer Cell Int2025https://conductscience.org/library/papers/41272764PubMed
41009692Emerging Biomarkers in Urological Cancers: Angiogenesis and Damage-Associated Molecular Pattern Signaling.Int J Mol Sci2025https://conductscience.org/library/papers/41009692PubMed
40909863The Role of MAPK12 in Prognosis of Patients With Liver Cancer and Effects on Stemness Characteristics.Stem Cells Int2025https://conductscience.org/library/papers/40909863PubMed
40544243Edaravone-Dexborneol slows down pathological progression and cognitive decline via inhibiting S100A9 in APPswe/PS1dE9 mice.Alzheimers Res Ther2025https://conductscience.org/library/papers/40544243PubMed
39844891Expression of miR-15b-5p and toll-like receptor4 as potential novel diagnostic biomarkers for hepatitis C virus-induced hepatocellular carcinoma.Noncoding RNA Res2025https://conductscience.org/library/papers/39844891PubMed
39638834Machine learning approach identifies inflammatory gene signature for predicting survival outcomes in hepatocellular carcinoma.Sci Rep2024https://conductscience.org/library/papers/39638834PubMed
39262476
Identifying epithelial-mesenchymal transition-related genes as prognostic biomarkers and therapeutic targets of hepatocellular carcinoma by integrated analysis of single-cell and bulk-RNA sequencing data.
Transl Cancer Res2024https://conductscience.org/library/papers/39262476PubMed
38817853S100A8-Mediated Inflammatory Signaling Drives Colorectal Cancer Progression via the CXCL5/CXCR2 Axis.J Cancer2024https://conductscience.org/library/papers/38817853PubMed
37994394Integration of single-cell and bulk RNA-sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/37994394PubMed
37990105EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma.Sci Rep2023https://conductscience.org/library/papers/37990105PubMed
37405532Establishment and Evaluation of Exosomes-Related Gene Risk Model in Hepatocellular Carcinoma.Biochem Genet2024https://conductscience.org/library/papers/37405532PubMed
36982351Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth.Int J Mol Sci2023https://conductscience.org/library/papers/36982351PubMed
36421698Culture of Cancer Cells at Physiological Oxygen Levels Affects Gene Expression in a Cell-Type Specific Manner.Biomolecules2022https://conductscience.org/library/papers/36421698PubMed
36232334S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma.Int J Mol Sci2022https://conductscience.org/library/papers/36232334PubMed
36041055S100A9 Derived from Chemoembolization-Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression.Adv Sci (Weinh)2022https://conductscience.org/library/papers/36041055PubMed
35992798Construction and experimental verification of user-friendly molecular subtypes mediated by immune-associated genes in hepatocellular carcinoma.Front Oncol2022https://conductscience.org/library/papers/35992798PubMed
35397536A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells.BMC Cancer2022https://conductscience.org/library/papers/35397536PubMed
35281615Differential Expression and Bioinformatics Analysis of tRF/tiRNA in Endometriosis Patients.Biomed Res Int2022https://conductscience.org/library/papers/35281615PubMed

See all 56 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AGER177PubTator's text mininghttps://conductscience.org/library/genes/177NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK35595PubTator's text mininghttps://conductscience.org/library/genes/5595NCBI Gene
S100A96280PubTator's text mininghttps://conductscience.org/library/genes/6280NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25907296

GET https://conductscience.org/api/papers/v1/25907296/cited_by?page=2